Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

OptiBiotix launches SlimBiome in US weight loss brand

OptiBiotix Health PLC (AIM:OPTI, OTC:OPBXF) saw its shares jump around 14% on Thursday, after it announced the launch of SlimBiome in Hydroxycut Hunger Control, a product from what it says is America’s top-selling weight loss supplement brand. The launch follows the first order announced in April 2025.

The product is now available online and in major retailers such as Walmart. Marketing includes results from two OptiBiotix studies showing reductions in hunger of 74% and 83%. Order for a second product application have been received, with launch planned later this year.

“We are pleased to announce the launch of products containing our patented award winning SlimBiome in the USA,” said Chief Executive Stephen O’Hara.

He added that the launch substantiates SlimBiome’s science and builds its brand in consumer markets worldwide.

In London, OptiBiotix shares gained 1.41p, or 13.8%, to change hands at 11.67p each.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK